Financial Data and Key Metrics Changes - Adjusted net profits attributable to owners grew 64.7% year-over-year to RMB 907 million [3][24] - Overall revenue increased by 28.8% year-over-year to RMB 3.86 billion [18] - Gross profit rose 24.6% year-over-year to RMB 2.84 billion, with a gross margin of 73.6% [21][24] - Monthly active users (MAU) grew 3.8% year-over-year to 276 million, while paying subscribers increased 34.1% year-over-year to 16.91 million [14][15] Business Line Data and Key Metrics Changes - Revenue from core photo, video, and design products grew 41.6% year-over-year to RMB 2.95 billion [18] - Revenue from international markets increased by 37.4% year-over-year, accounting for 38% of total revenue [18] - Revenue from leisure products accounted for 81% of overall photo, video, and design products revenue, while productivity tools accounted for 19% [18] Market Data and Key Metrics Changes - International markets saw significant growth, with new features attracting over 3 million new users from Europe [15] - The Meitu app topped the overall App Store charts in 52 countries and regions, and category charts in over 110 countries [15][16] - The penetration rate of Kaipai agents increased to approximately 11% [12] Company Strategy and Development Direction - The company focuses on AI applications in the photo and video industry, building industry-specific AI agent teams to enhance content creation [4][3] - A shift towards a model-agnostic strategy is emphasized, allowing for flexible deployment of various AI models [4][5] - The company aims to optimize resource allocation between proprietary and external models while increasing investment in vertical model training [24] Management Comments on Operating Environment and Future Outlook - Management remains cautiously optimistic about the business environment, noting the positive impact of AI capabilities on product development [31] - The company anticipates continued growth in productivity tools and international markets, with a focus on enhancing user stickiness through attractive features [15][17] - Future revenue growth is expected to be driven by an increase in high ARPU paying subscribers and the successful integration of AI agents [14][17] Other Important Information - The company has officially discontinued its cosmetic supply chain management services, which has been classified as a discontinued operation [17] - A share buyback plan of up to HKD 300 million has been announced, reflecting confidence in future development [27][28] - The company plans to provide quarterly updates on key operating metrics for its core business starting this year [26] Q&A Session Summary Question: Insights on AI fragmentation and its impact on business - Management noted that while there may be slight decreases in MAU, the overall growth from AI capabilities is positive, with high subscription penetration rates for productivity tools [31][32] Question: Expectations for 2026 and subscription contributions from AI agents - Management expects stable top-line growth in 2026, with a composition shift towards more productivity tools globally [38] Question: Future vertical sector expansions and user habits - The company is exploring extensions into various vertical applications and adapting to different user habits in international markets [66][70]

Financial Data and Key Metrics Changes - Adjusted net profits attributable to owners grew 64.7% year-over-year to RMB 907 million [4] - Overall revenue increased by 28.8% year-over-year to RMB 3.86 billion [17] - Gross profit in 2025 was RMB 2.84 billion, a year-on-year increase of 24.6%, with a gross margin of 73.6% [22] - Net profit attributable to owners under IFRS was around RMB 700 million in 2025, lower than RMB 800 million in 2024 due to one-time gains and expenses [26][27] Business Line Data and Key Metrics Changes - Revenue from the core business of photo, video, and design products grew by 41.6% year-over-year to RMB 2.95 billion [18] - Revenue from international markets grew by 37.4% year-over-year, accounting for 38% of total revenue in 2025 [18] - Revenue from products for leisure and productivity tools accounted for 81% and 19% of overall photo, video, and design products revenue respectively [18] Market Data and Key Metrics Changes - Monthly active users (MAU) grew 3.8% year-over-year to 276 million, with paying subscribers increasing 34.1% year-over-year to 16.91 million [14] - The subscription rate for productivity tools reached 9%, an increase of 3.1 percentage points from December 2024 [14] - The penetration rate of Kaipai agents increased to approximately 11% [11] Company Strategy and Development Direction - The company focuses on two core strategies: productivity and globalization, with sustained user growth [14] - Plans to build AI agent teams to enhance e-commerce content creation and improve user engagement [6][8] - Aiming to optimize recommendation mechanisms and launch attractive features to enhance user stickiness [16] Management Comments on Operating Environment and Future Outlook - Management remains cautiously optimistic about the advertising business despite slight revenue stagnation [19] - The company views the growth of AI capabilities positively, believing it will enhance product development and user engagement [33][35] - Future growth is expected to be driven by productivity tools and international market expansion [38][39] Other Important Information - The company has officially discontinued the low-margin cosmetic supply chain management services, classified as a discontinued operation [17] - A share buyback plan of up to HKD 300 million has been announced, reflecting confidence in future development [30] Q&A Session All Questions and Answers Question: Paying subscribers are slightly lower than the first half of the year, and MAU is slightly lower than those in June - Management noted that the decrease in MAU is a snapshot of the past month and does not reflect overall performance, attributing it to the absence of blockbuster features in December [34] Question: Expectations for the year 2026 and subscription contribution from agents - Management expects overall rates to grow similarly to 2025, with a composition shift towards more productivity tools globally [38] Question: Relationship between ARPU enhancement and agent functions - Management indicated that the introduction of agents has significantly contributed to ARPU growth, as users are willing to pay more for high-quality outputs [65] Question: Expansion of vertical sectors in 2026 - Management confirmed plans to extend vertical applications and target specific needs in various sectors, avoiding competition with larger companies [59] Question: User habits for production tools in international markets - Management acknowledged different user preferences and habits in international markets, emphasizing the need for tailored approaches [60][62]

Financial Data and Key Metrics Changes - ICBC's total assets exceeded RMB 53 trillion, with customer loans surpassing RMB 30 trillion, up RMB 2.13 trillion YoY [3] - Operating income rose 1.9% YoY to RMB 800 billion, with net profit reaching RMB 370 billion, up by 1% YoY [4] - The NPL ratio stood at 1.31%, down three basis points YoY, with a provision coverage ratio of 213.6% [7][4] Business Line Data and Key Metrics Changes - Customer loans, bond investments, and deposits grew by 7.5%, 19.6%, and 7.1% YoY respectively [5] - Corporate loans rose by 7.8% YoY, while personal business loans increased by 15% [5] - Green loans reached RMB 6.7 trillion, ranking number one in the industry, and inclusive loans totaled RMB 3.6 trillion, with a growth rate of 22.8% [6] Market Data and Key Metrics Changes - Cross-border RMB settlements grew 8% YoY to RMB 6.3 trillion, with RMB global payment services expanding to 44 countries and regions, up by 23% YoY [8] - The personal AUM exceeded RMB 25 trillion, with corporate clients reaching 14.75 million and retail clients hitting 780 million [9] Company Strategy and Development Direction - ICBC aims to deepen its five transformations, balancing progress with stability to deliver sustainable value for global shareholders [10] - The bank plans to enhance its financial services, focusing on technology-driven solutions and international operations [18][19] - ICBC is committed to integrating AI and digital technologies into its operations to improve efficiency and customer service [40][44] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in maintaining asset quality and profitability despite sector-wide pressures, with a focus on risk management [12][23] - The outlook for 2026 includes a commitment to building a world-class bank and enhancing financial services to support the real economy [16][21] Other Important Information - ICBC plans a total cash dividend of RMB 110.6 billion for 2025, with an interim dividend of RMB 50 billion and a final dividend of RMB 60 billion [4] - The bank's A-share and H-share dividend yields reached 4.22% and 5.99% respectively, demonstrating effective market value management [5] Q&A Session All Questions and Answers Question: Did ICBC achieve fundamental shifts in performance? What were the standout achievements for 2026? - Management highlighted the successful culmination of the 14th Five-Year Plan, with improved asset quality and profitability metrics [12][14] Question: What are the current pricing trends for corporate and retail loans? How do you project NIM trajectory in 2026? - The NIM is projected to continue declining but at a moderated pace, with early signs of stabilization in loan pricing [33][34] Question: Has ICBC upgraded its strategy in the fintech sector? What were the key achievements in AI application in 2025? - ICBC is advancing its digital transformation to AI ICBC, focusing on enhancing technological capabilities and implementing AI in various business scenarios [39][40] Question: What are ICBC's capital replenishment plans for 2026? How will dividend policies evolve? - ICBC emphasized its commitment to capital management and maintaining a high dividend payout ratio while balancing strategic growth [47][50] Question: What new achievements will ICBC make in supporting industry, commerce, and technological innovation? - ICBC plans to enhance its corporate credit allocation structure and support the modernization of the industrial system through targeted financial services [54][61]

Financial Data and Key Indicators Changes - By the end of 2025, total assets exceeded RMB 53 trillion, with customer loans surpassing RMB 30 trillion, up RMB 2.13 trillion year-over-year [3] - Operating income rose 1.9% year-over-year to RMB 800 billion, while net profit reached RMB 370 billion, up 1% year-over-year [4] - The non-performing loan (NPL) ratio stood at 1.31%, down 3 basis points year-over-year, with a provision coverage ratio of 213.6% [7][13] Business Line Data and Key Indicators Changes - Customer loans, bond investments, and deposits grew by 7.5%, 19.6%, and 7.1% year-over-year respectively [5] - Corporate loans rose by 7.8% year-over-year, with personal business loans increasing by 15% [5] - Green loans reached RMB 6.7 trillion, ranking number one in the industry, while inclusive loans totaled RMB 3.6 trillion, with a growth rate of 22.8% [6] Market Data and Key Indicators Changes - Cross-border RMB settlements grew 8% year-over-year to RMB 6.3 trillion, with RMB global payment services expanding to 44 countries and regions, up 23% year-over-year [9] - The international assets of ICBC reached RMB 491.6 billion, up 12.4% year-over-year, outpacing the group average of 9.5% [35] Company Strategy and Development Direction - ICBC aims to deepen its five transformations, balancing progress with stability to deliver sustainable value for global shareholders [10] - The bank plans to enhance its financial services, focusing on technology-driven solutions and integrating comprehensive financial services across client lifecycles [17][19] - ICBC is committed to supporting the internationalization of RMB and expanding its global clearing network [8][19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving good results in 2026, emphasizing the importance of adapting to market changes and maintaining high-quality risk control [20] - The bank's strategic focus will include enhancing digital capabilities and leveraging technology to improve operational efficiency and customer service [40][46] - Management highlighted the importance of balancing credit business with financial services to achieve long-term growth [16][17] Other Important Information - ICBC plans a total cash dividend of RMB 110.6 billion for 2025, with an interim dividend of RMB 50 billion and a final dividend of RMB 60 billion [4] - The bank's A-share and H-share dividend yields reached 4.22% and 5.99% respectively, demonstrating effective market value management [5] Q&A Session Summary Question: Did ICBC achieve fundamental shifts in performance? What were the standout achievements for 2026? - Management noted that 2025 marked a successful culmination of the 14th Five-Year Plan, with structural optimization and renewed growth drivers [11] Question: Can you provide an overview of the overall situation with asset quality? - Management confirmed that the NPL ratio improved to 1.31%, with proactive risk management ensuring overall controllability [21][22] Question: What are the current pricing trends for corporate and retail loans? How do you project NIM trajectory in 2026? - Management projected that NIM will continue to decline but at a moderated pace, with early signs of stabilization in loan pricing [31][32] Question: Has ICBC upgraded its strategy in the fintech sector? What were the key achievements in AI application in 2025? - Management confirmed the upgrade to Smart ICBC, focusing on AI applications across various business scenarios, achieving significant operational efficiencies [39][40] Question: What are ICBC's capital replenishment plans for 2026? Will dividend policies evolve? - Management emphasized the importance of capital management and indicated a commitment to maintaining a high dividend payout ratio while balancing strategic growth [47][48]

Financial Data and Key Metrics Changes - Adjusted net profits attributable to owners grew 64.7% year-over-year to RMB 907 million [3] - Overall revenue increased by 28.8% year-over-year to RMB 3.86 billion [17] - Gross profit in 2025 was RMB 2.84 billion, a year-on-year increase of 24.6%, with a gross margin of 73.6% [21][22] - The adjusted net profit attributable to owners was around RMB 970 million, reflecting a year-over-year increase of 64.7% [26] Business Line Data and Key Metrics Changes - Revenue from the core business of photo, video, and design products grew by 41.6% year-over-year to RMB 2.95 billion [18] - Paying subscribers for productivity tools grew 67.4% year-on-year, primarily driven by DesignKit and Kaipai [14] - Revenue from international markets grew by 37.4% year-over-year, accounting for 38% of total revenue in 2025 [18] Market Data and Key Metrics Changes - Monthly active users (MAU) grew 3.8% year-over-year to 276 million [13] - Paying subscribers grew 34.1% year-over-year to 16.91 million [13] - The penetration rate of Kaipai agents increased to approximately 11% [11] Company Strategy and Development Direction - The company focuses on two core strategies: productivity and globalization [13] - Plans to build AI agent teams to enhance e-commerce content creation and improve user engagement [5][7] - Aiming to optimize recommendation mechanisms and launch attractive features to enhance user stickiness [16] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the growth of productivity tools and the positive impact of AI capabilities on business performance [32][34] - The company anticipates a gradual increase in ARPU growth as subscription rates improve [17] - Management acknowledged the challenges posed by competition but emphasized the company's unique positioning in vertical markets [48][49] Other Important Information - The company has officially discontinued the cosmetic supply chain management services, classifying it as a discontinued operation [17] - A share buyback plan of up to HKD 300 million was announced, reflecting confidence in future development [29] Q&A Session Questions and Answers Question: Paying subscribers are slightly lower than the first half of the year, and MAU is slightly lower than those in June - Management noted that the decrease in MAU is a snapshot of the past month and attributed it to the absence of blockbuster features in December [32][33] Question: Expectations for the year 2026 and the contribution of agents to subscriptions - Management indicated that the overall growth rate for 2026 is expected to be similar to 2025, with a focus on productivity tools globally [35][36] Question: Relationship between agent functions and ARPU enhancement - Management explained that the introduction of agents has led to increased token consumption, contributing to ARPU growth [62]

Financial Data and Key Metrics Changes - In 2025, the group operating income was CNY 435 billion, an increase of 7.7% year-on-year. Insurance revenue reached CNY 288 billion, up by 3.4%. Group OPAT attributable to shareholders was CNY 36 billion, up by 6.1%, while net profit was CNY 53.5 billion, up by 19% [4][5] - The group EV stood at CNY 613 billion, reflecting a 9.1% increase from the end of 2024. The number of customers increased by 3.5% to 190 million, and AUM approached CNY 3.9 trillion, up by 9.8% [4][5] Business Line Data and Key Metrics Changes - The life insurance business achieved written premiums of CNY 211.6 billion, up by 4.5%. The core agent headcount was 46,000, with a 13-month persistence ratio exceeding 90% [9][10] - The P&C business recorded primary premium income of CNY 201 billion, with auto insurance premiums at CNY 110 billion (up by 3%) and non-auto premiums at CNY 91 billion (down by 3%). The underwriting combined ratio improved to 97.5%, down by 1.1 percentage points year-on-year [12][13] Market Data and Key Metrics Changes - The bank channel achieved written premiums of CNY 61.6 billion, up by 46.4%, with regular pay FYP at CNY 17 billion, up by 43%. The share of mid-tier customers and above reached 41%, up by 1.8 percentage points [11] - The NEV business generated CNY 25 billion in premiums, accounting for 22% of total auto premiums, with a renewal rate of 78.1% for individual customers [13][71] Company Strategy and Development Direction - The company aims to enhance its core business competitiveness, focusing on value-driven growth and improving operational efficiency. It plans to accelerate innovation in technology and expand inclusive insurance offerings nationwide [24][26] - The strategic focus includes health and elderly care, internationalization, and AI integration to improve service capabilities and customer experience [24][25] Management's Comments on Operating Environment and Future Outlook - Management highlighted the resilience of China's economy and the importance of adapting to a new interest rate environment. They emphasized the need for steady progress while ensuring quality and efficiency in operations [3][22] - The company anticipates both opportunities and challenges in the insurance industry, with a focus on technological advancements and demographic shifts creating new needs for risk protection [21][22] Other Important Information - The MSCI ESG rating was upgraded to the highest AAA level, reflecting the company's commitment to sustainable development [8] - The company has implemented a new accounting standard, which has positively impacted net assets, showing a CAGR of 9.5% since its introduction [7][8] Q&A Session All Questions and Answers Question: What do you think was your achievement for the 14th Five-Year Plan? - Management noted progress in market position, transformation results, and growth in new business drivers, particularly in P&C and life insurance sectors [19][20] Question: How was the bank channel performing? - The bank channel is progressing as planned, with significant improvements in regular premium business and partnerships with major banks [28][30] Question: What is the outlook for 2026? - The company aims for higher quality and stronger resilience, focusing on core business performance and advancing three major strategies [40][42] Question: How will the company maintain solvency amid interest rate changes? - Management emphasized improved business quality and asset-liability matching as key factors in maintaining strong solvency ratios [32][34] Question: What are the plans for AI investment? - The company is committed to large-scale AI adoption across core business scenarios to enhance efficiency and customer experience [25][80]

Financial Data and Key Metrics Changes - In 2025, the group operating income was CNY 435 billion, an increase of 7.7% year-on-year. Insurance revenue reached CNY 288 billion, up by 3.4%. Group net profit was CNY 53.5 billion, up by 19% [5][6] - The group OPAT attributable to shareholders was CNY 36 billion, reflecting a growth of 6.1% [5][7] - The group EV stood at CNY 613 billion, up 9.1% from the end of 2024, with net assets increasing by 3.7% to CNY 302 billion [5][8] Business Line Data and Key Metrics Changes - The life insurance business achieved written premiums of CNY 211.6 billion, up 4.5%, with a core agent headcount of 46,000 and a 13-month persistence ratio exceeding 90% [9][10] - The bank channel saw a significant increase in written premiums, reaching CNY 61.6 billion, up by 46.4%, with regular pay FYP growing by 43% [11] - The P&C business recorded primary premium income of CNY 201 billion, with auto insurance premiums at CNY 110 billion (up 3%) and non-auto premiums at CNY 91 billion (down 3%) [12][13] Market Data and Key Metrics Changes - The number of customers increased by 3.5% to 190 million, and the group AUM approached CNY 3.9 trillion, up by 9.8% [6] - The underwriting combined ratio for P&C business improved to 97.5%, down by 1.1 percentage points year-on-year, with underwriting profit rising by 81% to CNY 4.8 billion [12][13] Company Strategy and Development Direction - The company aims to enhance operational efficiency and service capability, focusing on becoming a top-tier insurance company with market leadership and international competitiveness [17][26] - CPIC plans to accelerate innovation in technology, expand inclusive insurance offerings, and strengthen agricultural support systems [24][26] - The company is committed to a health and elderly care strategy, enhancing specialized operations in health insurance and building a closed-loop pension finance system [24][26] Management's Comments on Operating Environment and Future Outlook - Management noted that the insurance industry is entering a critical phase with both opportunities and challenges, emphasizing the need for steady progress while ensuring quality and efficiency [22][23] - The company will focus on integrating AI into core business scenarios to boost efficiency and reshape processes [25][40] - Management expressed confidence in maintaining strong solvency ratios and improving business quality despite market volatility [32][34] Other Important Information - The MSCI ESG rating was upgraded to the highest AAA level, reflecting the company's commitment to sustainable development [9] - The company has launched various initiatives in health and elderly care, including CPIC Home and internet-based services [21][56] Q&A Session All Questions and Answers Question: What do you think was your achievement for the 14th five-year period? - Management highlighted growth in market position, transformation results, and improvements in health and elderly care services [20][21] Question: How was the bank channel performing? - Management confirmed that the bank channel is progressing as planned, with significant improvements in business quality and customer mix [28][30] Question: What is the outlook for 2026? - Management aims for higher quality and stronger resilience, focusing on core business performance and new growth drivers [36][40] Question: How will the company maintain solvency amid interest rate changes? - Management emphasized improved business quality and asset liability matching as key factors in maintaining strong solvency ratios [32][34] Question: What are the plans for AI investment? - Management plans to drive large-scale AI adoption across core business scenarios to enhance efficiency and customer experience [25][80]

Financial Data and Key Metrics Changes - In 2025, the group operating income was CNY 435 billion, an increase of 7.7% year-on-year. Insurance revenue reached CNY 288 billion, up by 3.4%. Group net profit was CNY 53.5 billion, up by 19% [3][4] - The group OPAT attributable to shareholders was CNY 36 billion, reflecting a growth of 6.1%. The group EV stood at CNY 613 billion, up by 9.1% from the end of 2024 [3][5] - The number of customers increased by 3.5% to 190 million, and the group AUM approached CNY 3.9 trillion, up by 9.8% [4] Business Line Data and Key Metrics Changes - The life insurance business achieved written premiums of CNY 211.6 billion, up by 4.5%. The core agent headcount was 46,000, with a 13-month persistence ratio exceeding 90% [7][9] - The bank channel recorded written premiums of CNY 61.6 billion, up by 46.4%, with regular pay FYP increasing by 43% [10] - The P&C business reported primary premium income of CNY 201 billion, with auto insurance premiums at CNY 110 billion (up by 3%) and non-auto premiums at CNY 91 billion (down by 3%) [11][12] Market Data and Key Metrics Changes - The underwriting combined ratio for P&C business improved to 97.5%, down by 1.1 percentage points year-on-year, with underwriting profit amounting to CNY 4.8 billion, up by 81% [11] - The NEV business generated CNY 25 billion in premiums, accounting for 22% of total auto premiums, with a renewal rate of 78.1% for individual customers [12][55] Company Strategy and Development Direction - The company aims to enhance operational efficiency and service capability to become a top-tier insurance company with market leadership and international competitiveness [15] - Future strategies include focusing on health and elderly care, internationalization, and AI adoption to drive efficiency and optimize customer experience [21][33] - The company plans to strengthen agricultural support systems and expand inclusive insurance offerings nationwide [20] Management's Comments on Operating Environment and Future Outlook - Management highlighted the resilience of China's economy and the importance of adapting to a new interest rate era, emphasizing the need for steady progress while ensuring quality and efficiency [19][20] - The company anticipates both opportunities and challenges in the insurance industry, particularly with demographic shifts and technological advancements [19][20] Other Important Information - The MSCI ESG rating was upgraded to the highest AAA level, reflecting the company's commitment to sustainable development [6] - The company has implemented a new accounting standard, resulting in a CAGR of 9.5% in net assets since its adoption [6] Q&A Session Summary Question: Achievements in the 14th Five-Year Plan and outlook for the 15th Five-Year Plan - Management noted significant progress in market position, transformation results, and growth drivers, particularly in P&C and life business [17][18] Question: Bank channel performance and future initiatives - The bank channel has met expectations, with improvements in regular pay business and partnerships with SOE banks [23][24] Question: Solvency ratio and maintaining dividend payouts - The company reported improved solvency due to better business quality and asset-liability matching, ensuring stability in dividend payouts [26][27] Question: Outlook for 2026 and profitability expectations - Management expressed confidence in maintaining solid performance, focusing on quality growth and operational efficiency [29][31]

Financial Data and Key Metrics Changes - Hua Medicine achieved a revenue growth of 93% in 2025, with sales reaching close to CNY 500 million, driven by a 91% increase in the number of packs sold [3][19][20] - The gross profit margin improved due to economies of scale, with the price per tablet reduced by 8.2% [20][24] - The company reported a significant reduction in distribution costs and selling expenses, which dropped to 33% of sales from nearly 60% in 2024 [20][21] Business Line Data and Key Metrics Changes - The establishment of over 180 professional sales teams contributed to the sales growth, covering over 3,000 hospitals and reaching over 150,000 patients in mainland China [4][19] - The commercialization strategy shifted from relying on partners to an in-house team, enhancing market access and sales performance [4][19] Market Data and Key Metrics Changes - Hua Medicine expanded its market access through the registration of dorzagliatin in Hong Kong and plans to penetrate Southeast Asia, targeting over 100 million diabetes patients [5][16] - The company received a five-year extension on its composition of matter patent, ensuring market exclusivity until 2034 [5][24] Company Strategy and Development Direction - The company is focusing on expanding its glucose homeostasis technology platform and exploring new indications for dorzagliatin, including obesity and neurodegenerative diseases [18][28] - Hua Medicine aims to leverage its digital platform for commercialization and enhance the productivity of its sales team [37] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving sales targets of CNY 1 billion by 2027, citing patent protection, stable pricing, and effective promotion strategies as key factors [34][39] - The company is optimistic about the long-term growth potential, especially as it continues to gather real-world evidence supporting the efficacy of dorzagliatin [22][42] Other Important Information - The company is exploring partnerships for international expansion and potential in-licensing opportunities to enhance its product portfolio [57] - Hua Medicine is committed to maintaining a strong capital position, with CNY 1 billion in gross cash available at the end of the year [24] Q&A Session Summary Question: What are the sales targets for the next two years? - Management remains confident in achieving CNY 1 billion in sales by 2027, supported by patent protection and stable pricing strategies [34][36] Question: What is the progress on the pipeline for the second generation GKA? - Management indicated that promising data from the second generation will guide interactions with regulatory agencies for product launch [33][34] Question: What are the operational expenses expected in the coming years? - Selling expenses are expected to stabilize around 30-35%, while R&D expenses will be maintained at approximately 30% to support ongoing research [46][52]

Financial Data and Key Metrics Changes - Hua Medicine achieved a revenue growth of 93% in 2025, with sales reaching approximately RMB 500 million, driven by a 91% increase in packs sold compared to 2024 [3][19][20] - The gross profit margin improved due to economies of scale, with a reduction in tablet price by 8.2% [20][24] - The company reported a significant decrease in losses, almost halving from previous periods, and achieved profitability for the first time [23][24] Business Line Data and Key Metrics Changes - The establishment of over 180 professional sales teams contributed to the sales growth, covering over 3,000 hospitals and reaching over 150,000 patients in mainland China [4][19] - The commercialization strategy shifted from relying on partners to an in-house team, which has proven effective in driving sales [4][19] Market Data and Key Metrics Changes - Hua Medicine expanded its market access through the introduction of dorzagliatin in Hong Kong and plans to penetrate Southeast Asia, targeting over 100 million diabetes patients [5][16] - The company received a five-year extension on its composition of matter patent, ensuring market exclusivity until 2034 [5][24] Company Strategy and Development Direction - The company is focusing on expanding its glucokinase activator program into new disease areas, including obesity and neurodegeneration, while maintaining a strong emphasis on diabetes management [2][18] - Hua Medicine is also exploring partnerships for international expansion and potential in-licensing opportunities to enhance its product offerings [28][56] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving sales targets of RMB 1 billion by 2027, citing patent protection, stable pricing, and an effective sales strategy as key factors [32][34] - The company is optimistic about the future growth trajectory, supported by positive real-world evidence and increasing physician engagement [22][42] Other Important Information - Hua Medicine is advancing its clinical pipeline, with ongoing studies exploring the efficacy of dorzagliatin in combination with other therapies, including GLP-1 agonists [12][15] - The company is committed to maintaining a strong capital position, with RMB 1 billion in gross cash available at the end of the year [24][25] Q&A Session Summary Question: Regarding sales targets and peak sales expectations - Management remains confident in achieving RMB 1 billion in sales by 2027, supported by patent protection and pricing strategies [32][34] Question: Pipeline progress and regulatory interactions - Management indicated that promising data from the second-generation GKA will guide interactions with regulatory agencies for product launch [33][34] Question: Operating expenses and commercialization strategy - Management outlined plans to maintain selling expenses while investing in sales force expansion, with R&D expenses expected to remain around 30% of sales [45][51]